HEALTH
New Hope for Autoimmune Diseases: Scientists Try Bold New Treatments
USAMon Nov 17 2025
Autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and lupus are tough to treat. Current treatments just calm down the immune system's attack on the body, but they don't fix the root cause. This means patients often face a lifetime of expensive medications, injections, or infusions with serious side effects. Plus, these treatments don't always work well.
But now, scientists are exploring new ways to reprogram the immune system instead of just suppressing it. These new treatments are still experimental and mostly for patients who haven't responded to other treatments. However, early results are promising, and people are hopeful.
One of these new treatments is CAR-T therapy, which was originally developed to treat cancer. It involves taking immune cells called T cells from a patient's blood, reprogramming them in a lab, and then putting them back into the patient. These reprogrammed cells can target and destroy the immune cells that are causing the autoimmune disease.
While CAR-T therapy is promising, it's also very expensive and time-consuming. Scientists are now looking for other ways to reprogram the immune system. One approach is using "peacekeeper" cells, which help calm down the immune system's attack. Another approach is using drugs called T cell engagers, which redirect the body's existing immune cells to target the problematic cells.
Scientists are also working on more precise treatments that only target the specific immune cells causing the problem. This could help avoid the side effects of wiping out large parts of the immune system. Additionally, researchers are exploring ways to predict and possibly prevent autoimmune diseases before they start.
continue reading...
questions
What are the ethical considerations in using CAR-T therapy, which was originally developed for cancer, for autoimmune diseases?
How do the ethical guidelines for human trials of reprogramming therapies ensure patient safety and informed consent?
How does the cost of CAR-T therapy compare to the long-term costs of current treatments for autoimmune diseases?
actions
flag content